Mirae Asset Global ETFs Holdings’s Surmodics SRDX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,469	Closed	-$193K	–	3166
2025 Q3	$193K	Sell	6,469 -1,156	-15%	-$38.6K	﹤0.01%	2338
2025 Q2	$227K	Sell	7,625 -551	-7%	-$15.9K	﹤0.01%	2215
2025 Q1	$250K	Buy	8,176 +327	+4%	+$11K	﹤0.01%	2204
2024 Q4	$311K	Buy	7,849 +226	+3%	+$8.79K	﹤0.01%	2153
2024 Q3	$296K	Buy	7,623 +1,115	+17%	+$45.1K	﹤0.01%	2173
2024 Q2	$274K	Buy	+6,508	New	+$222K	﹤0.01%	2111

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SRDX Position: Q4 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 6,469 shares — an estimated $193K sold.

Mirae Asset Global ETFs Holdings first reported a position in SRDX in Q2 2024 and held it in 6 quarters. The position peaked at $311K in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Mirae Asset Global ETFs Holdings reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 6,469 Surmodics shares in Q4 2025, an estimated $193K.
Mirae Asset Global ETFs Holdings first reported a position in Surmodics in Q2 2024 and held it in 6 quarters.
Mirae Asset Global ETFs Holdings's Surmodics position peaked at $311K in Q4 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.